Company Snapshot

Read it, Learn it and Do it for your investment Needs
Home > Market > Equity > Company Snapshot
Company Snapshot
Glenmark Pharmaceuticals Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code: 532296 NSE Symbol: GLENMARK P/E : 48.66
ISIN Demat: INE935A01035 Div & Yield %: 0.2 EPS : 51.73
Book Value: 855.71 Market Cap (Rs. Cr.): 71,047.24 Face Value : 1

Exchange

Stock Price Details
Last Price (₹) 2,479.50
Change 61.40 (2.50%)
Best Buy (₹) 0
Best Sell (₹) 0
Today's Range 2,432.40 - 2,536.85
52-Week Range 1,794.00 - 2,536.85
Beta (1 Year) 0.78
Chart
1 Day | 5 Day | 3 Month | 1 Year | 5 Year
Index Details
BSE 500, BSE HC, BSE Midcap, BSE Shariah 50
Corporate Announcements
Glenmark Pharmaceuticals Ltd soars 1.8%, rises for third straight session
Glenmark USA launches Calcium Gluconate Injection USP
Glenmark Pharma's US arm launches Calcium Gluconate injection in various formats
Glenmark Pharmaceuticals receives USFDA approval for Fluticasone Propionate Nasal Spray USP
Glenmark Pharmaceuticals to convene AGM
Glenmark Pharmaceuticals consolidated net profit rises 930.34% in the June 2026 quarter
Glenmark receives USFDA approval for expanded use of RYALTRIS® for pediatric patients
Glenmark Pharmaceuticals announces board meeting date
Glenmark Pharmaceuticals Ltd soars 0.08%, up for fifth straight session
Glenmark USA launches Olanzapine for Injection
Corporate Details
Incorporation Year : 1977
Chairman : Glenn Saldanha
Ownership Group : Indian Private
Sector : Pharmaceuticals
Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln
Registered Office :

Glenmark Pharmaceuticals Ltd
B/2 Mahalaxmi Chambers,
22 Bhulabhai Desai Road,
Mumbai,
Maharashtra - 400026,
Phone : 91-22-40189999,
Fax : 91-22-40189986
E-Mail : complianceofficer@glenmarkpharma.com
URL : http://www.glenmarkpharma.com
Investor Returns
Period Date Price() Returns (%)
1Week 21-Aug-2026 2,306.00 9.17
1Month 28-Jul-2026 2,184.90 15.22
3Month 29-May-2026 2,274.25 10.69
6Month 02-Mar-2026 2,123.50 18.55
1Year 28-Aug-2025 1,934.75 30.12
Mutual Funds Holding
Scheme Name % Holding Market Value (₹.Cr)
HDFC Mid Cap Fund 2.85 2995.25
Invesco India Mid Cap Fund 2.83 416.41
Invesco India Contra Fund 1.89 380.18
Kotak Arbitrage Fund 0.42 310.54
Invesco India Large & Mid Ca.. 2.55 300.00
Peer Groups : Pharmaceuticals - Indian - Bulk Drugs & Formln
Company Last Price() Change(%) 52Week High() 52Week Low() Market Cap()
Sun Pharmaceutical Industries Ltd 1,920.10 1.03 2,047.55 1,547.25 460,696.31
Zydus Lifesciences Ltd 1,187.00 -0.17 1,205.65 835.85 118,403.70
Cipla Ltd 1,418.00 -0.13 1,672.20 1,165.55 114,554.33
Laurus Labs Ltd 1,935.30 0.80 1,939.00 822.85 104,566.62
Lupin Ltd 2,175.00 0.48 2,530.00 1,881.80 99,455.32